Statements (22)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:alsoKnownAs |
gptkb:doramapimod
|
| gptkbp:CASNumber |
265129-71-3
|
| gptkbp:chemicalFormula |
C22H18F3N3O2
|
| gptkbp:clinicalTrialPhase |
Phase II
|
| gptkbp:developedBy |
gptkb:Boehringer_Ingelheim
|
| https://www.w3.org/2000/01/rdf-schema#label |
BIRB796
|
| gptkbp:intendedUse |
treatment of inflammatory diseases
|
| gptkbp:mechanismOfAction |
p38 MAP kinase inhibitor
|
| gptkbp:molecularWeight |
413.4 g/mol
|
| gptkbp:PubChem_CID |
CHEMBL1201732
9941576 |
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
diarrhea headache |
| gptkbp:studiedBy |
gptkb:Crohn's_disease
ulcerative colitis rheumatoid arthritis |
| gptkbp:UNII |
6Q6X5Q2B1Z
|
| gptkbp:bfsParent |
gptkb:p38_MAPK_pathway
|
| gptkbp:bfsLayer |
6
|